News
News from us and our partners
News
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
CEO spotlight: Thierry Abribat's third straight win
Sofinnova’s newest partners discuss their career paths
Sofinnova publishes 2023 Impact Report
Johnson & Johnson to acquire Shockwave Medical
Cure51 raises €15 million to harness the power of cancer survivors
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
- News
Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry's first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan
- News
Forth Tx launches with backing from Sofinnova Partners to revolutionize fibrosis treatments
- News
BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies
- News
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
- News
Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
- News
Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer
- News
May Health appoints seasoned medtech executive, Colby Holtshouse, as President and CEO
- News
T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development
- News
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
- News
Pi-Cardia Reports First Commercial Cases with ShortCut™
- Feature
Healthcare in the post-COVID era, where is Cell and Gene Therapy going?
- News
NanoPhoria Bioscience awarded €17.5 M from European Innovation Council’s accelerator program
- News
TISSIUM strengthens executive leadership team with key appointments
- News
Latent Labs secures $50M in funding to realize the potential of AI-powered, programmable biology